Securities Registration (section 12(b)) (8-a12b)
November 04 2016 - 4:47PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
NUGENE INTERNATIONAL, INC.
(Exact name of registrant as specified in its
charter)
NEVADA
|
|
46-3999052
|
(State or other jurisdiction of
incorporation)
|
|
(IRS Employer Identification
Number)
|
17912
Cowan
Irvine,
California 92614
(Address of Principal Executive Offices)
Securities to be registered pursuant to Section
12(b) of the Act:
|
Title of each class
|
|
Name of each exchange on which
|
|
To be so registered
|
|
Each class is to be registered
|
|
Common Stock, par value $.0001
|
|
OTC Marketplace
|
If
this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant
to General Instruction A.(c) or (e), check the following box.
þ
If this form relates to the registration of
a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e),
check the following box.
□
Securities to be registered pursuant to Section
12(g) of the Act: None.
Item 1. Description of Registrant’s
Securities to be Registered.
This registration statement relates to the
common stock, par value $0.0001 per share (the “
Common Stock
”), of NuGene International, Inc. (“
Registrant
”). The
description under the heading “
Description of Securities
” relating to the Registrant’s Common Stock in
the Registrant’s Current Report filed on Form 8-K (File No. 333-192997) (the “
Current Report
”),
originally filed under the Securities Act of 1933, as amended (the “
Securities Act
”), with the Securities and
Exchange Commission (the “
Commission
”) on January 06, 2015, is incorporated herein by reference. In addition,
any description of the Common Stock contained in a form of prospectus relating to a registration statement subsequently filed by
the Registrant pursuant to Rule 424(b) under the Securities Act shall be deemed to be incorporated by reference herein.
Item 2. Exhibits.
Under the Instructions as to Exhibits with
respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on
the OTC Marketplace and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities
Exchange Act of 1934, as amended.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: November 4, 2016
|
NUGENE INTERNATIONAL, INC.
|
|
|
|
By:
|
/s/ Steven R. Carlson
|
|
|
STEVEN R. CARLSON,
|
|
|
Chief Executive Officer
|
NuGene (PK) (USOTC:NUGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
NuGene (PK) (USOTC:NUGN)
Historical Stock Chart
From Apr 2023 to Apr 2024